Feasibility and safety of tailored dosing schedule for eculizumab based on therapeutic drug monitoring: Lessons from a prospective multicentric study.
Christophe PassotRebecca Sberro-SoussanDominique BertrandSophie CaillardBetoul SchvartzCamille DomengerCécile Contin-BordesGilles PaintaudJean-Michel HalimiDavid TernantPhilippe GataultPublished in: British journal of clinical pharmacology (2020)
Safe eculizumab interval adjustment is feasible with a PK monitoring.
Keyphrases